Get the latest tech news
After decades, FDA moves to pull ineffective decongestant off shelves
Last year, FDA advisors unanimously voted that oral phenylephrine is ineffective.
A box of Sudafed PE sinus pressure and pain medicine containing phenylephrine is displayed for sale in a CVS Pharmacy store in Hawthorne, California, on September 12, 2023. Credit: Getty | PATRICK T. FALLON A box of Sudafed PE sinus pressure and pain medicine containing phenylephrine is displayed for sale in a CVS Pharmacy store in Hawthorne, California, on September 12, 2023. Credit: Getty | PATRICK T. FALLON In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a common over-the-counter decongestant, which the agency concluded last year is not effective at relieving stuffy noses.
Or read this on Hacker News
